Connecticut
Go Back to Map ←Connecticut’s bioscience industry is an innovative and growing component of the overall U.S. economy. With a track record of generating high-quality jobs and steady growth, the bioscience industry has been a consistent engine for our economy and a key strength during past economic recessions. American innovation in bioscience helps support state and local communities in a variety of ways ranging from job creation, construction, tax revenues, and other economic impact values.
Driven by small-company innovators, the bioscience industry has also mobilized in an unprecedented manner to address the global COVID-19 pandemic, while continuing to develop other life-saving and life-enhancing products and services for the U.S. and the world. America’s bioscience industry as an innovator and economic driver has never been more important, both for our health and our economic stability.
View Facilities By District
| District | Total Facilities in District | View Facilities in District |
| CT01 | 1 |
VeraDermics Inc. |
| CT02 | 2 |
American Laboratory Trading (ALT) BioCT |
| CT03 | 17 |
Artificial Cell Technologies, Inc Azitra, Inc. Cybrexa Therapeutics EpiTET Therapeutics EvolveImmune Therapeutics, Inc. Intensity Therapeutics, Inc. InveniAI LLC Moexa Pharmaceuticals NanoViricides, Inc NextWaveBio OrphAI Therapeutics Osmol Therapeutics, Inc. Rallybio ReNetX Bio Trevi Therapeutics, Inc. Virscio, Inc. Weave Bio |
| CT04 | 2 |
Boehringer Ingelheim Braidwell LP |